Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
136.6 USD | -1.40% | -0.60% | +8.48% |
05/06 | European Equities Traded in the US as American Depositary Receipts Rise in Wednesday Trading | MT |
03/06 | Ascendis Pharma Reports 45% Clinical Response in TransCon IL-2 Phase 1/2 Trial | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+8.48% | 7.94B | |
+18.50% | 125B | |
+14.05% | 109B | |
-2.80% | 24.74B | |
+2.71% | 22.67B | |
-9.95% | 18.14B | |
-41.48% | 16.67B | |
-12.09% | 16.64B | |
+0.24% | 13.45B | |
+22.86% | 11.32B |
- Stock Market
- Equities
- ASND Stock
- News Ascendis Pharma A/S
- Earnings Flash (ASND) ASCENDIS PHARMA Reports Q3 Revenue EUR15.3M